Breaking News Instant updates and real-time market news.

ENPH

Enphase Energy

$20.19

(0.00%)

, EBAY

eBay

$39.03

(0.00%)

09:40
07/18/19
07/18
09:40
07/18/19
09:40

Unusually active option classes on open July 18th

Unusual total active option classes on open include: Enphase Energy (ENPH), EBay (EBAY), United Rentals (URI), IBM (IBM), Cloudera (CLDR), UnitedHealth (UNH), Kinder Morgan (KMI), Nokia (NOK), GDXJ (GDXJ), and Philip Morris (PM).

ENPH

Enphase Energy

$20.19

(0.00%)

EBAY

eBay

$39.03

(0.00%)

URI

United Rentals

$131.55

(0.00%)

IBM

IBM

$143.07

(0.00%)

CLDR

Cloudera

$5.48

(0.00%)

UNH

UnitedHealth

$266.71

(0.00%)

KMI

Kinder Morgan

$20.60

(0.00%)

NOK

Nokia

$5.17

(0.00%)

GDXJ

VanEck Vectors Junior Gold Miners

$37.66

(0.00%)

PM

Philip Morris

$81.06

(0.00%)

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 25

    Jul

  • 30

    Jul

ENPH Enphase Energy
$20.19

(0.00%)

06/12/19
RILY
06/12/19
INITIATION
Target $21
RILY
Buy
Enphase Energy resumed with a Buy at B. Riley FBR
B. Riley FBR analyst Dave Kang resumed coverage of Enphase Energy with a Buy rating and $21 price target. The analyst believes the company is set to post accelerating growth.
06/20/19
HCWC
06/20/19
DOWNGRADE
Target $16
HCWC
Neutral
Enphase Energy downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Amit Dayal downgraded Enphase Energy to Neutral from Buy citing valuation with the stock above his unchanged price target of $16. At current levels, the shares are more than adequately pricing in another earnings beat for Q2 and potential guidance raise for 2019, Dayal tells investors in a research note. He believes his $16 price represents fair valuation for Enphase Energy based on its current growth outlook.
06/20/19
06/20/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Novo Nordisk (NVO) downgraded to Hold from Buy at Deutsche Bank with analyst Richard Parkes citing valuation. 2. Shopify (SHOP) downgraded to Neutral from Outperformer at CIBC with analyst Todd Coupland stating that while he is encouraged by the company's product announcements, he believes the upside seen in his investment thesis has now been priced into the stock. 3. Enphase Energy (ENPH) downgraded to Neutral from Buy at H.C. Wainwright with analyst Amit Dayal saying at current levels, the shares are more than adequately pricing in another earnings beat for Q2 and potential guidance raise for 2019. 4. Hershey (HSY) downgraded to Underweight from Neutral at Piper Jaffray with analyst Michael Lavery stating the company has a U.S.-centric portfolio with generally stable sales and earnings growth, but the valuation at current share levels "now looks inconsistent with consensus expectations". 5. Carnival (CCL) downgraded to Market Perform from Outperform at William Blair with analyst Sharon Zackfia noting the company lowered expectations for the remainder of the fiscal year, with constant-currency net yields now expected to be flattish to slightly down in Q3 and down in Q4. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/19
NORL
06/26/19
INITIATION
Target $24
NORL
Outperform
Enphase Energy initiated with an Outperform at Northland
Northland analyst Gus Richard initiated Enphase Energy with an Outperform rating and $24 price target, noting that the company will enable grid independence without storage as it launches its iQ8 inverter early next year and in his view "the killer application for solar is grid independence. The Ensemble 2.0 product offering, enabled by iQ8, increases its revenue opportunity per home to $10,000 from $2,000, said Richard.
EBAY eBay
$39.03

(0.00%)

07/18/19
FBCO
07/18/19
NO CHANGE
Target $49
FBCO
Outperform
eBay price target raised to $49 from $43 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for eBay to $49 from $43 following quarterly results. The analyst reiterates an Outperform rating on the shares.
07/18/19
BNCH
07/18/19
NO CHANGE
Target $50
BNCH
Buy
eBay price target raised to $50 from $45 at Benchmark
Benchmark analyst Daniel Kurnos said eBay reported "another quarter of underwhelming" gross merchandise volume, but the magnitude of the tailwind from promoted listings and intermediated payments drove a slight revenue beat and allowed management to maintain its organic, currency neutral revenue growth guidance. The analyst, who raised his price target on eBay shares to $50 from $45 following the earnings report, noted that his valuation does not factor in any asset sales, which he estimates could represent upwards of $10 per share in added value. Kurnos keeps a Buy rating on eBay shares.
07/18/19
DBAB
07/18/19
NO CHANGE
Target $46
DBAB
Buy
eBay price target raised to $46 from $42 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for eBay to $46 from $42 citing last night's "strong" Q2 results. Although gross merchandise volume was was flat year-over-year excluding currency, which was largely anticipated based on third party data, revenue was up 4%, modestly above the Street on continued growth in Promoted Listings, Walmsley tells investors in a research note. He maintains a Buy rating on eBay shares.
07/18/19
DADA
07/18/19
NO CHANGE
Target $47
DADA
Buy
eBay price target raised to $47 from $44 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on eBay (EBAY) to $47 and kept his Buy rating after its above-consensus results in Q2, saying the activist investor involvement in the company is bringing out its "best" with "strong" operating metrics, margin expansion, and an "aggressive" buyback. The analyst adds that he found the company's answers about the implications of Facebook's (FB) Libra cryptocurrency efforts encouraging in its potential to reduce the transaction costs on eBay's platform.
URI United Rentals
$131.55

(0.00%)

12/14/18
LEHM
12/14/18
INITIATION
Target $130
LEHM
Equal Weight
United Rentals reinstated with an Equal Weight at Barclays
Barclays analyst Adam Seiden reinstated coverage of United Rentals with an Equal Weight rating and $130 price target. The analyst sees "slow, steady" low-to-mid single-digit growth for the rental industry in 2019, United Rentals included. He sees an even risk/reward at current share levels.
06/28/19
UBSW
06/28/19
NO CHANGE
Target $170
UBSW
Buy
United Rentals shares undervalued barring severe recession, says UBS
Barring a severe recession, shares of United Rentals are undervalued as the company is significantly different now versus prior downturns, UBS analyst Steven Fisher tells investors in a research note. The analyst estimates that a "relatively mild" recession, akin to 2001/2002, could result in a 5%-10% decline in EBITDA, versus the ~20% decline in EBITDA United Rentals experienced in 2002. He believes such a decline is largely priced into United Rentals shares at current levels. The analyst keeps a Buy rating on United Rentals with a $170 price target.
04/01/19
OTRG
04/01/19
DOWNGRADE
OTRG
Mixed
United Rentals downgraded to Mixed from Positive at OTR Global
OTR Global downgraded United Rentals to Mixed from Positive following checks that indicate flattening utilization and growth.
02/19/19
STPT
02/19/19
DOWNGRADE
STPT
Hold
United Rentals downgraded to Hold from Buy at Standpoint Research
IBM IBM
$143.07

(0.00%)

07/18/19
MSCO
07/18/19
NO CHANGE
MSCO
IBM showing growth 'in all the right places,' says Morgan Stanley
Morgan Stanley analyst Katy Huberty noted that IBM's Q2 revenue was "just in-line," but she said the company is showing growth in "all the right places" as the segments aligning with its strategy of helping customers digitally transform to cloud and cognitive enterprises were strong. Cloud & Data Software constant currency revenue growth accelerated to 5% and Global Business Services delivered revenue and margin expansion for another quarter, noted Huberty. The analyst, who added that she thinks the company's tone on the earnings conference call "seemed bullish," does not have a rating on IBM shares.
07/18/19
JPMS
07/18/19
INITIATION
Target $147
JPMS
Neutral
IBM reinstated with a Neutral at JPMorgan
JPMorgan analyst Tien-tsin Huang reinstated coverage of IBM with a Neutral rating and $147 price target following a period of restriction. The rating is unchanged while the price target is reduced from $160. The analyst, who views last night's Q2 results as "fine," says he lacks conviction on near-term stock upside potential from the Red Hat deal.
07/09/19
STFL
07/09/19
NO CHANGE
Target $169
STFL
Buy
Red Hat closing probably earlier than most expected, says Stifel
Stifel analyst David Grossman said IBM's (IBM) closing of its Red Hat (RHT) acquisition probably came earlier than most expected, adding that IBM will report standalone Q2 results next week, on July 17, and than will provide an update including Red Hat on a webcast scheduled for August 2. IBM is set up as a defensive holding with two potential catalysts, namely continued improvement in its core infrastructure services business and demonstrated success in leveraging Red Hat, said Grossman, who keeps a Buy rating and $169 price target on IBM shares.
07/18/19
NOMU
07/18/19
NO CHANGE
Target $165
NOMU
Buy
IBM price target raised to $165 from $160 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal raised his price target for IBM to $165 from $160 saying sales upside in the highest margin segments and a "solid" earnings beat in Q2 lifted visibility into the company's full-year guidance. The analyst keeps a Buy rating on IBM shares.
CLDR Cloudera
$5.48

(0.00%)

07/10/19
CHLM
07/10/19
NO CHANGE
Target $14
CHLM
Buy
Cloudera shift to open source the right move, says Craig-Hallum
Cloudera today announced that it is "100% committed to open source" as the company tries to transform itself following the merger with Hortonworks and imminent release of its Cloudera Data Platform, Craig-Hallum analyst Chad Bennett tells investors in a research note. He believes Cloudera's open source commitment was inspired by the success of Red Hat and is the right move. Red Hat offers all its software free of charge and charges its customers for consulting, support, and training services, which Cloudera will look to emulate, Bennett says. He keeps a Buy rating on Cloudera shares with a $14 price target.
06/06/19
BOFA
06/06/19
DOWNGRADE
Target $7
BOFA
Underperform
Cloudera downgraded to Underperform from Neutral at BofA/Merrill
BofA Merrill Lynch downgraded Cloudera to Underperform from Neutral and set a $7 price target on the stock following the company's Q1 results and guidance cut.
06/06/19
06/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qorvo (QRVO) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis citing the company's higher relative valuation, concerns of increased radio frequency competition, and potential further impacts from the trade war for the downgrade. 2. Spirit Airlines (SAVE) downgraded to Neutral from Buy at Goldman Sachs with analyst Catherine O'Brien saying there is downside risk to the consensus earnings forecasts for Spirit while United's estimates have appropriately incorporated tougher second half 2019 comparables. 3. Orange SA (ORAN) downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Cloudera (CLDR) downgraded two notches to Hold from Strong Buy at Needham, to Neutral from Buy at Citi, to Hold from Buy at Stifel, and to Market Perform from Outperform at Raymond James. 5. FuelCell (FCEL) downgraded to Perform from Outperform at Oppenheimer and to Market Perform from Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/01/19
MSCO
07/01/19
NO CHANGE
Target $145
MSCO
Overweight
Morgan Stanley still confident in Microsoft's Server & Tools division growth
Morgan Stanley analyst Keith Weiss noted that a key debate about Microsoft (MSFT), which has been stoked by recent weakness in other on-premise infrastructure software vendors such as Cloudera (CLDR), Pivotal Software (PVTL) and VMware (VMW), remains the durability of growth in the company's On-premise Server Products and Tools. However, he maintains confidence in the durability of low-single digital growth in the Server Products & Tools division, citing share gains across the solution portfolio. However, Weiss does note that Microsoft faces face unusually tough comparison in the division in Q4 and Q1 of FY20, leaving him to forecast year-over-year declines in these two quarters. He maintains an Overweight rating and $145 price target on Microsoft shares.
UNH UnitedHealth
$266.71

(0.00%)

07/16/19
PIPR
07/16/19
NO CHANGE
PIPR
Overweight
UnitedHealth coverage decision positive for Neuronetics, says Piper Jaffray
UnitedHealth (UNH) recently issued a coverage decision stating that theta burst TMS has been deemed "unproven and not medically necessary," which will make obtaining reimbursement from the insurer more difficult in the future for theta burst providers, Piper Jaffray analyst Matt O'Brien tells investors in a research note. This would specifically impact MagVentures, which has been mentioned frequently as a key competitor to monitor for Neuronetics (STIM), adds the analyst. The analyst says that with no changes to the reimbursement pathway for Neuronetics in the coverage update, he views the news as incrementally positive for the company as it competes in the theta-burst stimulation category for major depressive disorder patients. O'Brien reiterates an Overweight rating on Neuronetics and continues to view the name as his favorite small cap idea.
07/15/19
CLVD
07/15/19
NO CHANGE
CLVD
UnitedHealth continues to gain market share, says Cleveland Research
Cleveland Research analyst Steve Willoughby said earlier today that his recent work indicates UnitedHealth continues to gain share across both the UHC and OptumRx businesses. Feedback on the upcoming Medicare Advantage Annual Election Period points to UnitedHealth likely being best positioned to lead the market in membership growth, Willoughby wrote in a research note. The analyst's Q2, 2019 and 2020 estimates are ahead of consensus and keeps a Buy rating on UnitedHealth shares.
07/15/19
GSCO
07/15/19
DOWNGRADE
Target $85
GSCO
Sell
Goldman Sachs downgrades Quest Diagnostics to Sell, cuts target to $85
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics (DGX) to Sell from Neutral and lowered his price target for the shares to $85 from $90. The company remains in a flat- to low-single-digit organic growth environment which will constrain operating profit and free cash flow growth, Donnelly tells investors in a research note. Further, the analyst sees "little reason for optimism" in the near term around the UnitedHealth (UNH) Preferred Lab Network. The incentive structure to further narrow lab use is uncertain and "in-network" status is most likely to continue to dominate volume flow, says Donnelly. He sees downside risk to Quest's to out-year estimates "as the lab business struggles to grow organically."
07/11/19
SPHN
07/11/19
NO CHANGE
SPHN
Stephens raises targets for Anthem, Cigna, peers on HHS rebate rule withdrawal
Following press reports that the White House has withdrawn its proposed rule to eliminate drug rebates in Medicare/Medicaid outside point of sale, Stephens analyst Scott Fidel raised his price targets on a number of managed care stocks, calling the elimination of this key near-term overhang a "material positive event" for the MCO and PBM group. He raised his price target on Anthem (ANTM) to $350 from $335, upped his target on Cigna (CI) to $240 from $225, increased his target on Humana (HUM) to $320 from $300 and raised his target on UnitedHealth (UNH) to $290 from $270. Fidel keeps Overweight ratings on all four of those stocks. He also raised his target on Magellan Health (MGLN) to $74 from $70, though he keeps an Equal Weight rating on that stock, citing the company's softer fundamentals.
KMI Kinder Morgan
$20.60

(0.00%)

06/26/19
06/26/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. State Street (STT) downgraded to Neutral from Buy at UBS with analyst Brennan Hawken saying he has "very little confidence" in when the company will be able to get past the headwinds it is facing. 2. Allergan (AGN) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying she views the AbbVie (ABBV) deal as "a hard-fought and timely exit" for shareholders, citing her concerns about the weakness in Allergan's aesthetics portfolio and the company's growth challenges. 3. Kinder Morgan (KMI) downgraded to Market Perform from Outperform at Raymond James with analyst Justin Jenkins saying shares are up approximately 35% year-to-date and trade at an above-peer multiple despite a mixed outlook for the asset portfolio. 4. Papa John's (PZZA) downgraded to Neutral from Buy at Kalinowski. 5. Illinois Tool Works (ITW) downgraded to Sell from Neutral at Northcoast with the firm's analyst citing concentrated Automotive exposure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/17/19
STFL
06/17/19
DOWNGRADE
STFL
Hold
Kinder Morgan downgraded to Hold from Buy at Stifel
Stifel analyst Selman Akyol downgraded Kinder Morgan to Hold from Buy with an unchanged price target of $22. The analyst continues to view Kinder favorably given its recent reduction to "more moderate" leverage, high coverage, and dividend growth, but he believes the current valuation reflects this.
06/26/19
RAJA
06/26/19
DOWNGRADE
RAJA
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Raymond James
As previously reported, Raymond James downgraded Kinder Morgan to Market Perform from Outperform. Analyst Justin Jenkins said shares are up approximately 35% year-to-date and trade at an above-peer multiple despite a mixed outlook for the asset portfolio.
06/26/19
RAJA
06/26/19
DOWNGRADE
RAJA
Market Perform
Kinder Morgan downgraded to Market Perform from Outperform at Raymond James
NOK Nokia
$5.17

(0.00%)

07/11/19
MKMP
07/11/19
NO CHANGE
Target $54
MKMP
Buy
Ciena investment case is strengthening, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $54 price target on Ciena (CIEN), saying the "very good investment case" on the stock is "strengthening" after his discussions with the company's SVP of Global Products. The analyst notes that the company has been gaining 1%-1.5% of market share in China annually for the past 5 years and believes that it can gain another 1%-3% this year since the competitive intensity from Acacia (ACIA) and Nokia (NOK) "did not materialze".
07/01/19
SANT
07/01/19
UPGRADE
SANT
Buy
Nokia upgraded to Buy from Underweight at Santander
07/16/19
DADA
07/16/19
UPGRADE
DADA
Nokia upgraded to Buy from Hold at Danske Bank
Danske Bank analyst Fredrik Lithell upgraded Nokia to Buy from Hold and raised his price target for the shares to 5.20 euros from 5.0.
07/16/19
07/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. LabCorp (LH) upgraded to Neutral from Underperform at BofA/Merrill with analyst Derik De Bruin saying he has become increasingly more constructive on industry trends since January. 2. Timken (TKR) upgraded to Buy from Neutral at Goldman Sachs with analyst Joseph Ritchie saying he shuffled his ratings in the Americas Multi-Industry ahead of the Q2 earnings season. 3. Freeport McMoRan (FCX) upgraded to Equal Weight from Underweight at Barclays while Wheaton Precious Metals (WPM) was upgraded to Overweight from Equal Weight. 4. OneMain Holdings (OMF) upgraded to Overweight from Neutral at JPMorgan with analyst Richard Shane saying with the shares trading at almost a 30% discount to the peer median, the stock can deliver a mid- to high-teens return through 2020. 5. Nokia (NOK) upgraded to Buy from Hold at Danske Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GDXJ VanEck Vectors Junior Gold Miners
$37.66

(0.00%)

PM Philip Morris
$81.06

(0.00%)

05/28/19
SBSH
05/28/19
NO CHANGE
SBSH
Cigarette data from Nielsen 'dire,' industry data also 'very bad,' says Citi
Citi analyst Adam Spielman noted that Nielsen reported earlier today that cigarette industry volumes fell 11.2% in the four weeks ended May 18, noting that shares of Altria (MO), British American Tobacco (BTI) and Imperial (IMBBY) all fell following the "dire" data. Volumes in MSAi, the industry database that he regards as much more reliable than Nielsen, were down 6.4% in the same period, which Spielman said "is still a very bad figure, but it is a lot, lot better than the Nielsen one." Looking ahead, the analyst said he expects "gradually less bad" volumes in Nielsen in the rest of the year, though he noted that Altria has said it expects industry volumes to fall about 4%-5% this year and he forecasts a decline of about 6%. In late afternoon trading, Altria shares are down 4.5%, British American has declined over 4% and Philip Morris (PM) is down 5%.
07/16/19
WELS
07/16/19
NO CHANGE
WELS
Wells says Nielsen restatement could be positive for Monster, tobacco stocks
Wells Fargo analyst Bonnie Herzog noted that Nielsen (NLSN) just announced that it will restate data to address serious issues with its calculation methodology in the convenience store channel related to projections it applied to independent c-stores. The restated data, to be released on August 20, is expected to improve cigarette and energy drink trends and she views this as a positive for tobacco stocks and Monster Beverage (MNST). Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
07/01/19
PIPR
07/01/19
NO CHANGE
Target $100
PIPR
Overweight
Philip Morris checks in Japan show iQOS momentum, says Piper Jaffray
Piper Jaffray analyst Michael Lavery says his recent channel checks in Japan suggest "good momentum" for iQOS. The analyst continues to believe iQOS is the most compelling heated tobacco product and he maintains an Overweight rating on Philip Morris shares with a $100 price target.
06/19/19
WELS
06/19/19
NO CHANGE
Target $100
WELS
Outperform
Philip Morris recent selloff 'unjustified,' says Wells Fargo
Wells Fargo analyst Bonnie Herzog reiterates her bullish call on Philip Morris and believes the recent selloff in the stock is "unjustified." The analyst sees this as an opportunity for long-term investors to enter or build positions in what she believes is one of the "most attractive CPG stocks" in terms of growth prospects and yield characteristics. Herzog reiterates an Outperform rating and $100 price target on the shares.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

16:31
08/23/19
08/23
16:31
08/23/19
16:31
Hot Stocks
Qualcomm CFO Dave Wise to retire, Akash Palkhiwala named interim CFO »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

ANFI

Amira Nature Foods

$0.58

-0.0144 (-2.44%)

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Hot Stocks
Amira Nature Foods receives NYSE notice over late Form 20-F filing »

Amira Nature Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.